ACE2 and infection: The key, novel findings of this study are the demonstration that Lisinopril treatment leads to increased expression of ACE2 in the lungs, the main target organ of SARS-CoV-2, and this effect seems to be a key element making these animals susceptible to higher viral loads at the earlier and later stages of the infection.